Notice of Funding Opportunity (NOFO)

CDC-RFA-PS20-2001: Tuberculosis Elimination and Laboratory Cooperative Agreement

The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year 2020 funds under a new five-year cooperative agreement, in order to assist state, local, and territorial tuberculosis (TB) programs in preventing, controlling, and eventually eliminating TB in the United States.

This five year funding opportunity is a continuation of CDC’s investment over the past 30 years to ensure that essential elements of TB programs are preserved nationwide. While the primary responsibility for TB control and prevention rests with state and local health departments, federal CDC funds complement ongoing TB prevention, control, and laboratory services and activities at the local and state level.

This new cooperative agreement builds on the significant historical work of CDC and state and local TB programs, which was in large part responsible for the reversal of the 1985–1992 resurgence of TB in the United States. The resurgence was fueled by budget cuts, growing incidence of HIV infection, and the transmission of multidrug-resistant TB (MDR TB) in hospitals and other settings. CDC’s TB cooperative agreement funds continue to help ensure the downward TB incidence trends experienced in the United States over the past 20 years.